Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


14.06.2021

1 Ann Med
4 Ann Rheum Dis
5 Arthritis Res Ther
1 Clin Exp Rheumatol
4 Clin Rheumatol
1 Eur J Immunol
2 J Rheumatol
3 Rheumatol Int
1 Scand J Rheumatol
2 Z Rheumatol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Med

  1. ZHANG LL, Wu XX, Wang XF, Di DS, et al
    Genetic variant in microRNA-146a gene is associated with risk of rheumatoid arthritis.
    Ann Med. 2021;53:824-829.
    PubMed         Abstract available


    Ann Rheum Dis

  2. JAIN S, Dhir V, Aggarwal A, Gupta R, et al
    Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomised controlled trial.
    Ann Rheum Dis. 2021 Jun 10. pii: annrheumdis-2021-220512.
    PubMed         Abstract available

  3. PAULSHUS SUNDLISATER N, Aga AB, Olsen IC, Hammer HB, et al
    Joint tenderness and ultrasound inflammation in DMARD-naive patients with early rheumatoid arthritis.
    Ann Rheum Dis. 2021 Jun 3. pii: annrheumdis-2021-220265.
    PubMed        

  4. SPARKS JA, Wallace ZS, Seet AM, Gianfrancesco MA, et al
    Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
    Ann Rheum Dis. 2021 May 28. pii: annrheumdis-2021-220418.
    PubMed         Abstract available

  5. JOHNSON TM, Sayles HR, Baker JF, George MD, et al
    Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
    Ann Rheum Dis. 2021 May 28. pii: annrheumdis-2021-220125.
    PubMed         Abstract available


    Arthritis Res Ther

  6. HUR B, Gupta VK, Huang H, Wright KA, et al
    Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Arthritis Res Ther. 2021;23:164.
    PubMed         Abstract available

  7. DEMORUELLE MK, Wang H, Davis RL, Visser A, et al
    Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Arthritis Res Ther. 2021;23:163.
    PubMed         Abstract available

  8. FERRAZ-AMARO I, Corrales A, Quevedo-Abeledo JC, Vegas-Revenga N, et al
    Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk.
    Arthritis Res Ther. 2021;23:162.
    PubMed         Abstract available

  9. GIOLLO A, Cioffi G, Ognibeni F, Orsolini G, et al
    Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis.
    Arthritis Res Ther. 2021;23:158.
    PubMed         Abstract available

  10. MIYAZAKI Y, Nakano K, Nakayamada S, Kubo S, et al
    Serum TNFalpha levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.
    Arthritis Res Ther. 2021;23:154.
    PubMed         Abstract available


    Clin Exp Rheumatol

  11. DITTO MC, Parisi S, Varisco V, Talotta R, et al
    Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
    Clin Exp Rheumatol. 2021;39:546-554.
    PubMed         Abstract available


    Clin Rheumatol

  12. RINGER A, Ruffino JP, Leiva R, Cuadranti N, et al
    Chagas disease reactivation in rheumatologic patients: association with immunosuppressive therapy and humoral response.
    Clin Rheumatol. 2021;40:2955-2963.
    PubMed         Abstract available

  13. CHOI SR, Park JW, Lee EB, Park JK, et al
    Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
    Clin Rheumatol. 2021 Jun 11. pii: 10.1007/s10067-021-05811.
    PubMed         Abstract available

  14. NAJAFIZADEH SR, Amiri K, Moghaddassi M, Khanmohammadi S, et al
    Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.
    Clin Rheumatol. 2021 May 28. pii: 10.1007/s10067-021-05771.
    PubMed         Abstract available

  15. BARCELOS F, Martins C, Madeira N, Angelo-Dias M, et al
    Lymphocyte subpopulations in Sjogren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
    Clin Rheumatol. 2021;40:2791-2804.
    PubMed         Abstract available


    Eur J Immunol

  16. HENSVOLD A, Klareskog L
    Towards Prevention of Autoimmune Diseases: The Example of Rheumatoid Arthritis.
    Eur J Immunol. 2021 Jun 10. doi: 10.1002/eji.202048952.
    PubMed         Abstract available


    J Rheumatol

  17. SPARKS JA
    Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210224. doi: 10.3899/jrheum.210224.
    PubMed         Abstract available

  18. FERREIRA RJO, Landewe RBM, da Silva JAP
    Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?
    J Rheumatol. 2021 Jun 1. pii: jrheum.210050. doi: 10.3899/jrheum.210050.
    PubMed         Abstract available


    Rheumatol Int

  19. CHEVALLARD M, Belloli L, Ughi N, Adinolfi A, et al
    Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.
    Rheumatol Int. 2021;41:1253-1261.
    PubMed         Abstract available

  20. FAYET F, Pereira B, Fan A, Rodere M, et al
    Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study.
    Rheumatol Int. 2021 May 29. pii: 10.1007/s00296-021-04893.
    PubMed         Abstract available

  21. TANAKA K, Kimura E, Oryoji K, Mizuki SI, et al
    Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
    Rheumatol Int. 2021 Jun 6. pii: 10.1007/s00296-021-04889.
    PubMed         Abstract available


    Scand J Rheumatol

  22. TAN YK, Teo P, Saffari SE, Xin X, et al
    A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2021 Jun 10:1-9. doi: 10.1080/03009742.2021.1901416.
    PubMed         Abstract available


    Z Rheumatol

  23. SIEROCINSKI E, Angelow A, Mainz A, Walker J, et al
    [Patient safety in the treatment of rheumatic diseases : Laboratory monitoring in methotrexate treatment].
    Z Rheumatol. 2021;80:418-424.
    PubMed         Abstract available

  24. VALOR-MENDEZ L, Manger B, Schett G, Kleyer A, et al
    [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].
    Z Rheumatol. 2021 Jun 7. pii: 10.1007/s00393-021-01020.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: